Corebridge Financial’s CareDx CDNA Stock Holding History

Corebridge Financial’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-25,190	Closed	-$447K	–	507
2025 Q1	$447K	Buy	25,190 +52	+0.2%	+$1.12K	﹤0.01%	1661
2024 Q4	$538K	Sell	25,138 -1,897	-7%	-$46.1K	﹤0.01%	1650
2024 Q3	$844K	Buy	27,035 +210	+0.8%	+$5.22K	﹤0.01%	1443
2024 Q2	$417K	Buy	+26,825	New	+$324K	﹤0.01%	1792

Other funds holding CDNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OAM

Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

Corebridge Financial's CDNA Position: Q2 2025 in Review

Corebridge Financial sold out of CareDx (CDNA) in Q2 2025, closing a stake of 25,190 shares — an estimated $447K sold.

Corebridge Financial first reported a position in CDNA in Q2 2024 and held it in 4 quarters. The position peaked at $844K in Q3 2024. 197 funds tracked by Wall St. Rank hold CDNA as of Q2 2025.

Corebridge Financial reported no remaining CareDx position as of Q2 2025 after selling out during the quarter.
Corebridge Financial sold 25,190 CareDx shares in Q2 2025, an estimated $447K.
Corebridge Financial first reported a position in CareDx in Q2 2024 and held it in 4 quarters.
Corebridge Financial's CareDx position peaked at $844K in Q3 2024.
197 funds tracked by Wall St. Rank held CareDx as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.